Literature DB >> 11435239

Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study.

C Tabak1, I C Arts, H A Smit, D Heederik, D Kromhout.   

Abstract

Flavonoids have been suggested to protect against chronic lung disease. We studied intake of catechins, flavonols, and flavones in relation to pulmonary function and COPD symptoms in 13,651 adults from three Dutch cities examined from 1994 to 1997. Dietary intake was estimated using a food frequency questionnaire, and flavonoid intake was calculated using specific food composition tables. Pulmonary function (FEV1) was determined by spirometry and COPD symptoms by questionnaire. Associations were presented for the fifth versus the first quintile of intake (Q5-Q1), adjusted for age, height (for FEV1 only), sex, smoking, BMI, and energy intake. Smoking was strongly associated with COPD, independent of dietary effects. Average catechin, flavonol, and flavone intake was 58 mg/d (SD = 46) with tea and apples as main sources. Total catechin, flavonol, and flavone intake was positively associated with FEV1 (beta(Q5-Q1) = 44 ml, 95% CI = 18-69) and inversely associated with chronic cough (OR(Q5-Q1) = 0.80, 95% CI = 0.66-0.97) and breathlessness (OR(Q5-Q1) = 0.74, 95% CI = 0.58- 0.94), but not chronic phlegm. Catechin intake was independently associated with FEV1 (beta(Q5-Q1) = 130 ml, 95% CI = 101-159) and all three COPD symptoms (OR(Q5-Q1) = 0.60-0.72, p < 0.001). Flavonol and flavone intake was independently associated with chronic cough only. Solid fruit, but not tea, intake was beneficially associated with COPD. Our results suggest a beneficial effect of a high intake of catechins and solid fruits against COPD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435239     DOI: 10.1164/ajrccm.164.1.2010025

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  56 in total

1.  Patterns of dietary intake and relation to respiratory disease, forced expiratory volume in 1 s, and decline in 5-y forced expiratory volume.

Authors:  Tricia M McKeever; Sarah A Lewis; Patricia A Cassano; Marga Ocké; Peter Burney; John Britton; Henriette A Smit
Journal:  Am J Clin Nutr       Date:  2010-06-16       Impact factor: 7.045

Review 2.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

3.  The Association Between Dietary Intake and Phenotypical Characteristics of COPD in the ECLIPSE Cohort.

Authors:  Corrine Hanson; Harlan Sayles; Erica E P A Rutten; E F M Wouters; William MacNee; Peter Calverley; Jane L Meza; Stephen Rennard
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

4.  Selected food processing techniques as a factor for pesticide residue removal in apple fruit.

Authors:  Magdalena Słowik-Borowiec; Ewa Szpyrka
Journal:  Environ Sci Pollut Res Int       Date:  2019-11-28       Impact factor: 4.223

Review 5.  Plant polyphenols as dietary antioxidants in human health and disease.

Authors:  Kanti Bhooshan Pandey; Syed Ibrahim Rizvi
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

6.  Diet and airway obstruction: a cross sectional study from the second Korean National Health and Nutrition Examination Survey.

Authors:  Jin Hwa Lee; Yun Su Sim; Gee Young Suh; Jeong-Seon Ryu; Dong Ho Shin; Kyung Haeng Koh; Yeon Jae Kim; Wan Park; Hyoung Kyu Yoon; Man Jae Lee; Jung Hyun Chang
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

7.  Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Sangbrita S Chattoraj; Asamanja Chattoraj; John R Burgess; Jeffrey L Curtis; Fernando J Martinez; Suzanna Zick; Marc B Hershenson; Uma S Sajjan
Journal:  Respir Res       Date:  2010-09-28

8.  The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction.

Authors:  Patrick Geraghty; Andrew A Hardigan; Alison M Wallace; Oleg Mirochnitchenko; Jincy Thankachen; Leo Arellanos; Victor Thompson; Jeanine M D'Armiento; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

Review 9.  Antioxidant therapies in COPD.

Authors:  Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Soy consumption and risk of COPD and respiratory symptoms: a case-control study in Japan.

Authors:  Fumi Hirayama; Andy H Lee; Colin W Binns; Yun Zhao; Tetsuo Hiramatsu; Yoshimasa Tanikawa; Koichi Nishimura; Hiroyuki Taniguchi
Journal:  Respir Res       Date:  2009-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.